Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc (BHC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,101,608
  • Shares Outstanding, K 354,951
  • Annual Sales, $ 8,601 M
  • Annual Income, $ -1,788,000 K
  • 60-Month Beta 1.14
  • Price/Sales 0.72
  • Price/Cash Flow 1.66
  • Price/Book 11.30

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.96
  • Number of Estimates 7
  • High Estimate 1.07
  • Low Estimate 0.87
  • Prior Year 1.19
  • Growth Rate Est. (year over year) -19.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.18 +8.83%
on 09/11/20
17.68 -6.59%
on 09/17/20
+0.13 (+0.79%)
since 08/21/20
3-Month
15.18 +8.83%
on 09/11/20
22.97 -28.08%
on 08/06/20
-3.06 (-15.63%)
since 06/19/20
52-Week
11.15 +48.16%
on 03/18/20
31.97 -48.33%
on 12/13/19
-6.34 (-27.73%)
since 09/20/19

Most Recent Stories

More News
Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics

and , /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and Bausch + Lomb, its leading global eye health business, and Allegro Ophthalmics, LLC (Allegro), a privately held...

BHC : 16.52 (-3.90%)
Bausch Foundation Releases Inaugural Activity Report

, /PRNewswire/ -- The Bausch Foundation ("Foundation"), which oversees and directs the charitable giving efforts of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today released its ,...

BHC : 16.52 (-3.90%)
Sol-Gel Technologies Collaboration Partner Filed First-to-File Paragraph IV Certification for Duobrii(R)

Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin...

PRGO : 45.92 (-2.44%)
SLGL : 7.31 (-2.92%)
BHC : 16.52 (-3.90%)
Australia's TGA Approves BAUSCH + LOMB ULTRA® ONE DAY Silicone Hydrogel Daily Disposable Contact Lenses

, /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that it has received approval from Therapeutic...

BHC : 16.52 (-3.90%)
Bausch + Lomb Launches Innovative Bausch + Lomb INFUSE™ Silicone Hydrogel (SiHy) Daily Disposable Contact Lenses

, /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced the launch of Bausch + Lomb INFUSE™ silicone...

BHC : 16.52 (-3.90%)
Health Canada Approves BAUSCH + LOMB ULTRA ONE DAY® Silicone Hydrogel Daily Disposable Contact Lenses

, /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that it has received approval from Health Canada...

BHC : 16.52 (-3.90%)
Bausch (BHC) Q2 Earnings & Revenues Miss Estimates, Down Y/Y

Bausch (BHC) misses on earnings and sales in the second quarter and announces plans to spin off its eye care division.

RDY : 69.78 (-3.63%)
NVS : 89.50 (-1.58%)
SUPN : 21.50 (-3.80%)
BHC : 16.52 (-3.90%)
Bausch Health (BHC) Q2 Earnings and Revenues Miss Estimates

Bausch (BHC) delivered earnings and revenue surprises of -28.79% and -8.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

BHC : 16.52 (-3.90%)
Sol-Gel Technologies Reports Second Quarter 2020 Financial Results and Corporate Update

Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin...

PRGO : 45.92 (-2.44%)
SLGL : 7.31 (-2.92%)
BHC : 16.52 (-3.90%)
Bausch Health Companies Inc. Announces Second-Quarter 2020 Results

, /PRNewswire/ --

BHC : 16.52 (-3.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade BHC with:

Business Summary

Bausch Health Companies Inc. develops and distributes drugs. It develops drugs for unmet medical needs in central nervous system disorders and distributes generic and branded generic drugs primarily in Latin America and Eastern Europe. Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals,...

See More

Key Turning Points

2nd Resistance Point 17.04
1st Resistance Point 16.78
Last Price 16.52
1st Support Level 16.23
2nd Support Level 15.95

See More

52-Week High 31.97
Fibonacci 61.8% 24.02
Fibonacci 50% 21.56
Fibonacci 38.2% 19.10
Last Price 16.52
52-Week Low 11.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar